PubMed Health⌕ Search

Biomedical subjects

Ole Andersen

Publications and source records attributed to Ole Andersen.

21 records · Page 2Linked to original sources

Bioaugmentation of tar-contaminated soils under field conditions using Pleurotus ostreatus refuse from commercial mushroom production.

The influence of the white rot fungus Pleurotus ostreatus on the degradation of selected poly- and heterocyclic aromatic hydrocarbons (referred to as polycyclic aromatic hydrocarbons [PAHs]) in soil was investigated under field conditions representing the Northern temperate zone. Pleurotus ostreatus was added to two contaminated soils in the form of homogenized refuse from the commercial production of fungus. The soils were collected from a former shipyard (the B&W soil) and underneath a former coal tar storage at an old asphalt factory in Denmark (the Ringe soil). Treatments (control, soil mixed with autoclaved sawdust medium, and soil mixed with P. ostreatus refuse) were set up in triplicate in concrete cylinders (height, 50 cm; diameter, 60 cm). The activity of P. ostreatus was measured as laccase activity and phenanthrene (PHE)- and pyrene (PYR)-degrading bacteria were enumerated. Twenty-one different PAHs were quantified. After nine weeks the concentrations of the 3-, 4-, 5-, and 6-ring PAHs in the Ringe soil were reduced by 78, 41, and 4%, respectively. These reductions corresponded with high initial laccase activity, a decrease in pH caused by the fungus, and an increase in the number of PHE- and PYR-degrading bacteria. No significant PAH degradation was observed in the B&W soil. Reasons for the difference in performance of P. ostreatus in the two soils are discussed in terms of soil histories and bioavailability. The use of P. ostreatus refuse holds promising potential for bioremediation purposes.

Bacteria↗

Metabolism of pyrene by the polychaetes Nereis diversicolor and Arenicola marina.

Absorption and elimination of [(14)C-4,5,9,10]pyrene and production of water-insoluble and water-soluble pyrene metabolites by the polychaetes Nereis diversicolor and Arenicola marina were studied. Both polychaete species were capable of rapidly accumulating and eliminating pyrene. Steady state concentrations of pyrene were established in both polychaete species within 5 days of exposure to contaminated sediments, with A. marina having 5-10 times higher bioaccumulation factors than N. diversicolor. Both water-soluble and water-insoluble metabolites were detected in tissues of N. diversicolor and A. marina. After transferring worms to uncontaminated sediment, about 50% of the body burden of parent pyrene was excreted within 1.5 days, with elimination in A. marina being faster than in N. diversicolor. The only identified water-insoluble metabolite produced by N. diversicolor was 1-hydroxypyrene. Pyrene metabolites were present in A. marina, but could not be identified. Long- and short-term absorption experiments showed an increasing production of water-soluble metabolites over time in the lugworm, which strongly suggests the presence of a PAH metabolising system in A. marina.

Absorption↗

Molecular mechanisms of in vivo metal chelation: implications for clinical treatment of metal intoxications.

Successful in vivo chelation treatment of metal intoxication requires that a significant fraction of the administered chelator in fact chelate the toxic metal. This depends on metal, chelator, and organism-related factors (e.g., ionic diameter, ring size and deformability, hardness/softness of electron donors and acceptors, route of administration, bioavailability, metabolism, organ and intra/extracellular compartmentalization, and excretion). In vivo chelation is not necessarily an equilibrium reaction, determined by the standard stability constant, because rate effects and ligand exchange reactions considerably influence complex formation. Hydrophilic chelators most effectively promote renal metal excretion, but they complex intracellular metal deposits inefficiently. Lipophilic chelators can decrease intracellular stores but may redistribute toxic metals to, for example, the brain. In chronic metal-induced disease, where life-long chelation may be necessary, possible toxicity or side effects of the administered chelator may be limiting. The metal selectivity of chelators is important because of the risk of depletion of the patient's stores of essential metals. Dimercaptosuccinic acid and dimercaptopropionic sulfonate have gained more general acceptance among clinicians, undoubtedly improving the management of many human metal intoxications, including lead, arsenic, and mercury compounds. Still, development of new safer chelators suited for long-term oral administration for chelation of metal deposits (mainly iron), is an important research challenge for the future.

Biological Availability↗